BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo X, Wu F, Guo W, Zhang J, Yang Y, Lu Y, Yin C, Fan H, Xu J, Liao M. Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure. J Int Med Res 2020;48:300060520932053. [PMID: 32552092 DOI: 10.1177/0300060520932053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lei Y, Liang Y, Zhang X, Wang X, Zhang Y, Chan YM, Tang C, Zheng Z. Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF). Clin Case Rep 2021;9:e05220. [PMID: 34938567 DOI: 10.1002/ccr3.5220] [Reference Citation Analysis]
2 Chen Y, Luo Y, Wu F, Liao N, Shi Q, Mao D. Traditional Chinese medicine enema for acute chronic liver failure: A protocol of systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore) 2020;99:e22585. [PMID: 33031310 DOI: 10.1097/MD.0000000000022585] [Reference Citation Analysis]
3 Tan Y, Ye Y, Chen L. Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review. Open Med (Wars) 2021;16:553-7. [PMID: 33869777 DOI: 10.1515/med-2021-0267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Soares Ferreira Júnior A, Hodulik K, Barton KD, Onwuemene OA. Hemostatic effects of therapeutic plasma exchange: A concise review. J Clin Apher 2022. [PMID: 35196407 DOI: 10.1002/jca.21973] [Reference Citation Analysis]
5 Xu W, Li Y, Wang L, Gao H, Chen J, Yuan J, Ouyang Y, Gao Y, Li J, Li X, Peng L. Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial. BMJ Open 2021;11:e047690. [PMID: 34907041 DOI: 10.1136/bmjopen-2020-047690] [Reference Citation Analysis]
6 Chen YY, Li H, Xu BY, Zheng X, Li BL, Wang XB, Huang Y, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Zhang YH, Meng ZJ; Chinese Chronic Liver Failure (CLIF) Consortium. Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study. Front Med (Lausanne) 2021;8:779744. [PMID: 34869500 DOI: 10.3389/fmed.2021.779744] [Reference Citation Analysis]
7 Yang CF, Zhang Z, Zhang XY, Li YM. Artificial liver support system in pediatric acute liver failure due to mushroom poisoning: Case series. Ann Hepatol 2021;23:100290. [PMID: 33221398 DOI: 10.1016/j.aohep.2020.100290] [Reference Citation Analysis]
8 Shang J, Wang M, Wen Q, Ma Y, Chen F, Xu Y, Liu CH, Bai L, Tang H. A novel prognostic model to predict outcome of artificial liver support system treatment. Sci Rep 2021;11:7510. [PMID: 33820919 DOI: 10.1038/s41598-021-87055-8] [Reference Citation Analysis]